Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02898116
Brief Title: Phase 1/2 Study of Ensartinib and Durvalumab, in ALK-rearranged Non-small Cell Lung Cancer

First Submitted : September 8, 2016
First Submitted that Met QC Criteria : September 12, 2016
First Posted : September 13, 2016 (Estimate)

Results First Submitted : July 26, 2018
Results First Submitted that Met QC Criteria : July 26, 2018
Results First Posted : August 21, 2018

Last Update Submitted that Met QC Criteria : October 25, 2018
Last Update Posted : November 21, 2018